Á¦23ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2023-06-30
±³À°ÀÏÀÚ : 2023-06-30
±³À°Àå¼Ò : ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï ÄÚ¿¢½º B1 ´ÙÀ̾Ƹóµå·ë
±³À°ÁÖÁ¦ : Á¦23ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ
´ã´çÀÚ : ±èÈ£Á¤
¿¬¶ôó : 055-910-2187
À̸ÞÀÏ : ksimd2014@naver.com
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, ½Å°æ°ú, Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀÎ : 80¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 45ºÐ
¼¼ºÎ¼ö°·á : 70,000¿ø
ºñ°í »çÀüµî·Ï(ȸ ¿ø): Àü¹®ÀÇ 4¸¸¿ø, Àü°øÀÇ ¶Ç´Â Çлý 3¸¸¿ø, ±âŸ 4¸¸¿ø»çÀüµî·Ï(ºñȸ¿ø): Àü¹®ÀÇ 6¸¸¿ø, Àü°øÀÇ ¶Ç´Â Çлý 5¸¸¿ø, ±âŸ6¸¸¿ø ÇöÀåµî·Ï(ȸ ¿ø): Àü¹®ÀÇ 5¸¸¿ø, Àü°øÀÇ ¶Ç´Â Çлý 4¸¸¿ø, ±âŸ 5¸¸¿øÇöÀåµî·Ï(ºñȸ¿ø): Àü¹®ÀÇ 7¸¸¿ø, Àü°øÀÇ ¶Ç´Â Çлý 6¸¸¿ø, ±âŸ 7¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 10:00~10:40 Challenges and future scope of exosomes in the treatment of intractable diseases including IMD Á¶½Ö±¸(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 10:40~11:20 Research journey of elucidation of pathophysiology and therapeutic strategy focusing on Krabbe disease and I-cell disease Norio Sakai( )
ÈÞ½Ä 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 11:20~11:30 Break Time ( )
±³À°½Ã°£ 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 11:30~12:00 Experience in prenatal diagnosis and counseling of IMD À¯ÀºÁ¤(Â÷ÀÇ´ë)
½Ä»ç 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 12:00~13:00 ½Ä»ç ( )
±³À°½Ã°£ 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 13:00~13:25 Newborn screening of IMD by whole genome sequencing: opportunities and challenges ±ââ¼®(GCÁö³ð)
±³À°½Ã°£ 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 13:25~13:50 Screening newborns for IMD based on NeoSeq (Update) ¼º¹®¿ì(¼¿ïÀÇ´ë)
±âŸ 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 13:50~14:50 oral presentation ( )
ÈÞ½Ä 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 14:50~15:10 Break Time & Poster rounding ( )
±³À°½Ã°£ 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 15:10~15:35 Lysosomal storage disorders: the need for better pediatric recognition and comprehensive care Á¶¼ºÀ±(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 15:35~16:00 How to detect late-onset IMD in patients with movement disorders ÀÌÀçÇõ(ºÎ»êÀÇ´ë)
ÈÞ½Ä 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 16:00~16:10 Break Time ( )
±³À°½Ã°£ 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 16:10~16:35 Therapeutic unmet needs in Fabry disease and the underlying mechanisms À̹üÈñ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 16:35~17:00 Unravelling pathophysiology of Mucopolysaccharidosis type II using cerebral organoid ÀüÁ¾±Ù(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 06¿ù 30ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 17:00~17:25 Modeling of IMD using patient-specific induced pluripotent stem cells ÀÌÀçö(¼º±Õ°ü¾à´ë)